Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman Goossens

Showing results (461-470 of 485) with videos related to

Pageof 49
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2017
Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence SurveyYiying Cai, Indumathi Venkatachalam, Nancy W Tee, et al.
Critical Care (London, England)|November 15, 2022
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Bruno François, Marc Bourgeois, et al.
Annals of the American Thoracic Society|April 9, 2020
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C Angus, Scott Berry, Roger J Lewis, et al.
Lancet (London, England)|December 17, 2019
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trialChristopher C Butler, Alike W van der Velden, Emily Bongard, et al.
BMJ Open Respiratory Research|July 30, 2021
Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe-results from the PED-MERMAIDS multicentre case-control studyMalte Kohns Vasconcelos, Katherine Loens, Louise Sigfrid, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 11, 2024
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2026
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final reportJannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
Nature Communications|May 10, 2024
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countriesBiljana Kakaraskoska Boceska, Tuba Vilken, Basil Britto Xavier, et al.
The Lancet. Infectious Diseases|February 23, 2025
Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational studyLouise Sigfrid, Xin Hui S Chan, Louella M R Kasbergen, et al.
The Lancet. Infectious Diseases|February 23, 2025
Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational studyLouella M R Kasbergen, Erwin de Bruin, Felicity Chandler, et al.
Pageof 49

Showing results (461-470 of 485) with videos related to

Sort By:
Pageof 49
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2017
Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence SurveyYiying Cai, Indumathi Venkatachalam, Nancy W Tee, et al.
Critical Care (London, England)|November 15, 2022
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Bruno François, Marc Bourgeois, et al.
Annals of the American Thoracic Society|April 9, 2020
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C Angus, Scott Berry, Roger J Lewis, et al.
Lancet (London, England)|December 17, 2019
Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trialChristopher C Butler, Alike W van der Velden, Emily Bongard, et al.
BMJ Open Respiratory Research|July 30, 2021
Aetiology of acute respiratory infection in preschool children requiring hospitalisation in Europe-results from the PED-MERMAIDS multicentre case-control studyMalte Kohns Vasconcelos, Katherine Loens, Louise Sigfrid, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 11, 2024
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 8, 2026
Immunogenicity, reactogenicity and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED) - final reportJannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, et al.
Nature Communications|May 10, 2024
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countriesBiljana Kakaraskoska Boceska, Tuba Vilken, Basil Britto Xavier, et al.
The Lancet. Infectious Diseases|February 23, 2025
Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational studyLouise Sigfrid, Xin Hui S Chan, Louella M R Kasbergen, et al.
The Lancet. Infectious Diseases|February 23, 2025
Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational studyLouella M R Kasbergen, Erwin de Bruin, Felicity Chandler, et al.
Pageof 49